Clinical Trials on Prostate Hyperplasia

Total 7775 results

H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Benign Prostatic Hyperplasia | Prostate Carcinoma

United States
Fuzhou General Hospital

Completed

Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate

BPH With Large Prostate

China
Leiden University Medical Center

Completed

Effect of Deep BLock on Intraoperative Surgical Conditions (BLISS)

Renal Disease | Prostate Hypertrophy

Netherlands
Butterfly Medical Ltd.

Recruiting

Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL)

BPH | BOO - Bladder Outflow Obstruction | Enlarged Prostate (BPH)

Israel
Assiut University

Not yet recruiting

Outcomes of Water Vapor Thermal Therapy (REZUM) in Management of Symptomatic Patients With Benign Prostatic Enlargement

Benign Prostatic Hyperplasia
NeoTract, Inc.

Not yet recruiting

RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up (RELIEF)

Benign Prostatic Hyperplasia
Assiut University

Not yet recruiting

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia
Second Affiliated Hospital, School of Medicine,...

Recruiting

Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume

Benign Prostatic Hyperplasia

China
Jewish General Hospital

Not yet recruiting

Middle Lobe Only Laser Vaporization or Total Prostate Vaporization of the Prostate, Prospective Cohort Study

Benign Prostatic Hyperplasia
Zenflow, Inc.

Recruiting

The Zenflow Spring System EU Safety and Performance Study (ZEST EU)

Benign Prostatic Hyperplasia

Australia, New Zealand
REMD Medical Technology
RenJi Hospital; Tongji Hospital; Qilu Hospital of Shandong University; Sun Yat-Sen... and other collaborators

Completed

Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

China
Bioaraba Health Research Institute

Completed

Effectiveness of Smartconsent in Improving Understanding of Informed Consent (SMARTCONSENT)

Benign Prostatic Hyperplasia

Spain
Helwan University

Completed

Prostate Bipolar Enucleation and Resection Versus Open Prostatectomy

Benign Prostatic Hyperplasia

Egypt
Merit Medical Systems, Inc.

Terminated

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin

Benign Prostatic Hyperplasia

United States
University Hospital Southampton NHS Foundation...
BTG International Inc.

Unknown

Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement

Benign Prostatic Hyperplasia

United Kingdom
National Institute of Diabetes and Digestive and...
George Washington University

Completed

Botulinum Toxin Injection for the Management of BPH (MIST2)

Benign Prostatic Hyperplasia

United States
Kafrelsheikh University

Unknown

Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Egypt
James B. Spies, MD

Completed

Prostate Embolization for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Group of Research in Minimally Invasive Techniques
Universidad de Zaragoza; Hospital Clínico Universitario Lozano Blesa

Withdrawn

Prospective Controlled Randomized Study of PAE vs TURP for BPH Treatment.

Benign Prostatic Hyperplasia

Spain
Laboratoires Bouchara-Recordati
ClinSearch

Completed

Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH (UROEVAL)

Benign Prostatic Hyperplasia

France
Jena University Hospital
Boston Scientific Corporation

Completed

Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia (EmboProstate)

Benign Prostatic Hyperplasia

Germany
Mansoura University

Completed

GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT

Benign Prostatic Hyperplasia

Egypt
Siami, Paul F., M.D.
GlaxoSmithKline

Completed

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Merck Sharp & Dohme LLC

Terminated

Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)

Benign Prostatic Hyperplasia
Yuyu Pharma, Inc.

Completed

Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil

Benign Prostatic Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

AVODART(Dutasteride) Post-marketing Surveillance(PMS) (AVO PMS)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

Korea, Republic of
Ausio Pharmaceuticals, LLC

Completed

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, India
Golden Biotechnology Corporation

Completed

Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Taiwan
Chong Kun Dang Pharmaceutical

Completed

Study to Compare the Safety and Pharmacokinetics of CKD-397 (CKD-397)

Benign Prostatic Hyperplasia

Korea, Republic of
Kaiser Permanente

Completed

A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Astellas Pharma Inc
Boehringer Ingelheim; Astellas Pharma Europe Ltd.

Completed

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

Benign Prostatic Hyperplasia
RECORDATI GROUP

Completed

Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia (SiRE)

Benign Prostatic Hyperplasia

Italy
Allergan

Completed

A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; American Medical Systems

Completed

TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management (REVAPRO)

Benign Prostatic Hyperplasia

France
JW Pharmaceutical
Chonbuk National University Hospital; Samsung Medical Center; Seoul St. Mary's... and other collaborators

Completed

Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH) (STRONG)

Benign Prostatic Hyperplasia

Korea, Republic of
GlaxoSmithKline

Completed

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia | Benign Prostatic Hyperplasia

China
Samsung Medical Center

Unknown

Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg

Benign Prostatic Hyperplasia

Korea, Republic of
Eli Lilly and Company

Completed

Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Taiwan, Japan
innoVactiv Inc.

Completed

Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto

Benign Prostatic Hyperplasia

Canada
Eli Lilly and Company

Completed

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers

Benign Prostatic Hyperplasia

United States, Puerto Rico
GlaxoSmithKline

Completed

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Benign Prostatic Hyperplasia
Watson Pharmaceuticals

Completed

The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months

Benign Prostatic Hyperplasia

United States
Southwest Hospital, China

Unknown

Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate

Benign Prostatic Hyperplasia

China
University of California, Irvine
Pomegranate Health; Jarrow Pharmaceuticals

Unknown

Study of the Effects of Pomegranate Tablets on Enlarged Prostates

Benign Prostatic Hyperplasia

United States
Watson Pharmaceuticals

Completed

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Benign Prostatic Hyperplasia

United States
Sanofi

Completed

Once Daily Given Alfuzosin in the Treatment of BPH

Benign Prostatic Hyperplasia

Hungary
ProstaPlant Urology System Ltd.

Unknown

Evaluation of the ProstaPlant Prostate Stent Insertion in Ex Vivo Human Prostate

Benign Prostatic Hyperplasia

Israel
Medi-Tate Ltd.

Completed

Study to Assess the Efficacy of Medi-Tate iTind Device

Benign Prostatic Hyperplasia (BPH)

Spain, Belgium, Italy, Switzerland, United Kingdom
GemVax & Kael

Completed

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of

Clinical Trials on Prostate Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations